Literature DB >> 10940679

Frontotemporal dementia can be distinguished from Alzheimer's disease and subcortical white matter dementia by an anterior-to-posterior rCBF-SPET ratio.

M Sjögren1, L Gustafson, C Wikkelsö, A Wallin.   

Abstract

Sixteen patients with frontotemporal dementia (FTD), 27 with early-onset Alzheimer's disease, 25 with late-onset Alzheimer's disease, 19 with subcortical white matter dementia (SWD) and 28 normal controls underwent semiquantitative regional cerebral blood flow measurement (rCBF) using single-photon emission tomography (SPET; (99m)Tc-HMPAO) and either computerized tomography (CT) or magnetic resonance imaging (MRI) of the brain. An anterior-to-posterior rCBF-SPET ratio (mesial superior frontal gyrus/medial temporal lobes) was calculated, which significantly separated the FTD group from the other dementia groups and controls with a sensitivity of 87.5% and a specificity of at least 78.6%. CT/MRI was found to be helpful in the differential diagnosis between FTD and SWD. In FTD patients, the mesial superior frontal gyrus, near the polus frontalis, was found to be the region with the most reduced rCBF values. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10940679     DOI: 10.1159/000017250

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  10 in total

Review 1.  Organic psychosis: Insight into the biology of psychosis.

Authors:  N T Lautenschlager; H Förstl
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 2.  Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.

Authors:  Hilary A Archer; Nadja Smailagic; Christeena John; Robin B Holmes; Yemisi Takwoingi; Elizabeth J Coulthard; Sarah Cullum
Journal:  Cochrane Database Syst Rev       Date:  2015-06-23

3.  Diagnosis of Alzheimer's disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy?

Authors:  Takao Kubota; Yo Ushijima; Kei Yamada; Chio Okuyama; Osamu Kizu; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-11-20       Impact factor: 9.236

4.  Differential diagnosis of dementia with Lewy Bodies and Alzheimer Disease using combined MR imaging and brain perfusion single-photon emission tomography.

Authors:  H Goto; K Ishii; T Uemura; N Miyamoto; T Yoshikawa; K Shimada; S Ohkawa
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

Review 5.  Systematic review of the diagnostic utility of SPECT imaging in dementia.

Authors:  Jing Ming Yeo; Xuxin Lim; Zubair Khan; Suvankar Pal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-08-06       Impact factor: 5.270

6.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.

Authors:  Katya Rascovsky; John R Hodges; David Knopman; Mario F Mendez; Joel H Kramer; John Neuhaus; John C van Swieten; Harro Seelaar; Elise G P Dopper; Chiadi U Onyike; Argye E Hillis; Keith A Josephs; Bradley F Boeve; Andrew Kertesz; William W Seeley; Katherine P Rankin; Julene K Johnson; Maria-Luisa Gorno-Tempini; Howard Rosen; Caroline E Prioleau-Latham; Albert Lee; Christopher M Kipps; Patricia Lillo; Olivier Piguet; Jonathan D Rohrer; Martin N Rossor; Jason D Warren; Nick C Fox; Douglas Galasko; David P Salmon; Sandra E Black; Marsel Mesulam; Sandra Weintraub; Brad C Dickerson; Janine Diehl-Schmid; Florence Pasquier; Vincent Deramecourt; Florence Lebert; Yolande Pijnenburg; Tiffany W Chow; Facundo Manes; Jordan Grafman; Stefano F Cappa; Morris Freedman; Murray Grossman; Bruce L Miller
Journal:  Brain       Date:  2011-08-02       Impact factor: 13.501

7.  Sensitivity and specificity of neuroimaging for the diagnosis of Alzheimer's disease.

Authors:  Daniel E Wollman; Isak Prohovnik
Journal:  Dialogues Clin Neurosci       Date:  2003-03       Impact factor: 5.986

Review 8.  Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.

Authors:  Geetika Nehra; Bjoern Bauer; Anika M S Hartz
Journal:  Pharmacol Ther       Date:  2022-01-30       Impact factor: 13.400

Review 9.  Brain SPECT as a Biomarker of Neurodegeneration in Dementia in the Era of Molecular Imaging: Still a Valid Option?

Authors:  Rodolfo Ferrando; Andres Damian
Journal:  Front Neurol       Date:  2021-05-10       Impact factor: 4.003

Review 10.  Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies.

Authors:  Anders Wallin; Arto Nordlund; Michael Jonsson; Kaj Blennow; Henrik Zetterberg; Annika Öhrfelt; Jacob Stålhammar; Marie Eckerström; Mårten Carlsson; Erik Olsson; Mattias Göthlin; Johan Svensson; Sindre Rolstad; Carl Eckerström; Maria Bjerke
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.